Register information Protection certificate

DE file number : 12 2019 000 046.1 (Status: pending/in force, Query started: April 29, 2025)

Please note: This English version is a non-binding translation of the German register excerpt. Only the German version of the register excerpt is legally binding.

Master data
INIDCriterionFieldContent
Type of IP rightSARTProtection certificate
StatusSTPending/in force
21DE file number DAKZ12 2019 000 046.1
UseVZMedicinal products
95Product nameTIEZBrigatinib, oder ein pharmazeutisch unbedenkliches Salz davon
54Title of basic patentTIGZPHOSPHOR-DERIVATE ALS KINASE-INHIBITOREN
51IPC main classICM
(ICMV)
A61K 31/505 (2006.01)
51IPC secondary class(es)ICS
(ICSV)
A61K 31/513 (2006.01)
94Start of term of protectionLBMay 22, 2029
94End of term of protectionLENov 26, 2033
22DE application dateDATMay 17, 2019
Date of publication of application for a certificateOTJul 4, 2019
Date of publication of grant of certificatePETJan 2, 2025
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, 1-1, Doshomachi 4-chome, Chuo-ku, 541-0045 Osaka, JP
74RepresentativeVTRAbitz & Partner Patentanwälte mbB, 81925 München, DE
Address for service Abitz & Partner Patentanwälte mbB, 81628 München, DE
Due dateFT
FG
May 31, 2029
Annual fee for the 21st year Patent fees
Patent division in charge 44
68DE file number of basic patentGAKZ60 2009 048 183.5
68EP file number of basic patentGEAKZ09 75 1617.3
43Date of first publicationEVTJul 4, 2019
92
92
92
Domestic authorisationGIS
GIN
GIT
Europäische Kommission
EU/1/18/1264
2018-11-22
93
93
93
93
EU authorisationGES
GEC
GEN
GET
Europäische Kommission
EU
EU/1/18/1264
2018-11-22
Date of the first transfer into DPMAregisterEREGTJul 4, 2019
Date of the (most recent) update in DPMAregisterREGTJan 2, 2025
(Show all update days)(Hide all update days)
  • Jan 2, 2025
    • Date of publication of grant of certificate: new
    • Procedures: Supplementary protection certificate procedure, Certificate granted, 26.10.2024: changed
  • Nov 24, 2024
    • Procedures: Supplementary protection certificate procedure, Certificate granted, 26.10.2024: new
  • Sep 25, 2024
    • End of term of protection: new
    • Due date: new
    • Procedures: Supplementary protection certificate procedure, Decision to grant certificate by Patent Division, 24.09.2024: new
  • Jul 20, 2024
    • St.36: changed (technical change)
  • Sep 21, 2021; Jul 16, 2019
    • Historical data not available for this/these date(s)
  • Jul 4, 2019
    • Date of the first transfer into DPMAregister
Procedural data
No.Kind of procedureLegal statusDate of legal/procedural statusPublication dateAlle Details anzeigen
1 Supplementary protection certificate procedure Application for supplementary protection certificate effectively filed May 24, 2019 Jul 4, 2019 Details anzeigen
2 New applicant/owner details New applicant/owner details Sep 20, 2021  Details anzeigen
3 Supplementary protection certificate procedure Decision to grant supplementary protection certificate by Patent Division Sep 24, 2024  Details anzeigen
4 Supplementary protection certificate procedure Supplementary protection certificate granted Oct 26, 2024 Jan 2, 2025 Details anzeigen
View procedures Supplementary protection certificate procedure (No.: 1)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTApplication for supplementary protection certificate effectively filed
Date of legal/procedural statusVSTTMay 24, 2019
Issue numberHN27
YearPJ2019
Publication dateVTJul 4, 2019
Type of publicationPARTBibliographic data
PartHTPart 7
68DE file number of basic patentGAKZ60 2009 048 183.5
68EP file number of basic patentGEAKZ09 75 1617.3
View procedures New applicant/owner details (No.: 2)
INIDCriterionFieldContent Close details
Type of procedureVARTNew applicant/owner details
Legal/procedural statusVSTNew applicant/owner details
Date of legal/procedural statusVSTTSep 20, 2021
71/73Applicant/ownerINHTakeda Pharmaceutical Company Limited, 541-0045 Osaka, JP
71/73Previous applicant/ownerINHFAriad Pharmaceuticals, Inc., Cambridge, MA 02139, US
Date of update of the procedureREGTSep 21, 2021
View procedures Supplementary protection certificate procedure (No.: 3)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTDecision to grant supplementary protection certificate by Patent Division
Date of legal/procedural statusVSTTSep 24, 2024
Date of update of the procedureREGTSep 25, 2024
View procedures Supplementary protection certificate procedure (No.: 4)
INIDCriterionFieldContent Close details
Type of procedureVARTProtection certificate procedure
Legal/procedural statusVSTSupplementary protection certificate granted
Date of legal/procedural statusVSTTOct 26, 2024
Issue numberHN1
YearPJ2025
Publication dateVTJan 2, 2025
Type of publicationPARTBibliographic data
PartHTPart 7
Date of update of the procedureREGTJan 2, 2025